- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00514111
Factors Associated to Success of Hepatitis C Therapy
March 19, 2009 updated by: UPECLIN HC FM Botucatu Unesp
The aim of this study is to evaluate the sustained virologic response (RVS) in HVC patients treated with pegylated-interferon or conventional-interferon and ribavirin, and to investigate the associated factors with RVS, by means of retrospective analysis.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Chronic hepatitis C virus(HVC) is a major public-health problem since it presents a long phase of clinical latency which makes its early diagnosis difficult and results in the development of a large number of cases to complications such as cirrhosis, hepatic insufficiency and hepatocarcinoma.
In Brazil, it is estimated three million estimated cases to 52 thousand reports.
The aim of this study is to evaluate the sustained virologic response (RVS) in HVC patients treated with pegylated-interferon or conventional-interferon and ribavirin, and to investigate the associated factors with RVS, by means of retrospective analysis.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sao Paulo
-
Botucatu, Sao Paulo, Brazil, 18618970
- SAE e Hospital Dia de Aids
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
HVC patients attended in SAE e HD.
Description
Inclusion Criteria:
- HVC patients that received specific treatment with pegylated-interferon or conventional-interferon, and ribavirin
Exclusion Criteria:
- No HVC infection or treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
HVC Patients
HVC patients attended in SAE e HD.
|
Genotype 1: pegylated-interferon 2a or 2b plus ribavirin for 48 weeks.
Genotype 3: conventional-interferon 2a or 2b plus ribavirin for 24 weeks.
Other Names:
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2007
Primary Completion (Actual)
July 1, 2008
Study Completion (Actual)
December 1, 2008
Study Registration Dates
First Submitted
August 8, 2007
First Submitted That Met QC Criteria
August 8, 2007
First Posted (Estimate)
August 9, 2007
Study Record Updates
Last Update Posted (Estimate)
March 20, 2009
Last Update Submitted That Met QC Criteria
March 19, 2009
Last Verified
March 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Liver Diseases
- Flaviviridae Infections
- Hepatitis, Viral, Human
- Enterovirus Infections
- Picornaviridae Infections
- Hepatitis
- Hepatitis A
- Hepatitis C
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Antiviral Agents
- Antimetabolites
- Antineoplastic Agents
- Interferons
- Ribavirin
Other Study ID Numbers
- upeclin/HC/FMB-Unesp-16
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
-
UPECLIN HC FM Botucatu UnespCompletedHepatitis B, Chronic | Hepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedBrazil
-
UPECLIN HC FM Botucatu UnespUnknownHIV Infections | Acquired Immune Deficiency Syndrome | Hepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedBrazil
-
Fundacion para la Investigacion Biomedica del Hospital...Fundación Mutua MadrileñaCompletedHepatocellular Carcinoma | Acquired Immunodeficiency Syndrome Virus | Hepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedSpain
-
Institut National de la Santé Et de la Recherche...Not yet recruitingViral Hepatitis C | Liver Cancer | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Chronic Liver Disease and Cirrhosis | Viral Hepatitis B | Viral Hepatitis D
-
Beijing Friendship HospitalRecruitingChronic Hepatitis b | Non-Alcoholic Fatty Liver DiseaseChina
-
IlDong Pharmaceutical Co LtdUnknown
-
Fudan UniversityUnknownNon-Hodgkin Lymphoma | Hepatitis B ReactivationChina
-
ANRS, Emerging Infectious DiseasesUnknownChronic Hepatitis CFrance
-
University of CalgaryGlaxoSmithKline; Canadian Institutes of Health Research (CIHR)CompletedVaccine Reaction | Hepatitis B | Non-Alcoholic Fatty Liver DiseaseCanada
-
Humanity and Health Research CentreRecruitingChronic Hepatitis B | Nonalcoholic Fatty Liver DiseaseChina
Clinical Trials on pegylated-interferon, conventional-interferon, ribavirin
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedChronic Hepatitis C | GenotypeTaiwan
-
Sociedad Andaluza de Enfermedades InfecciosasCompletedHIV Infections | Hepatitis C, ChronicSpain
-
Dayanand Medical College and HospitalCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Hepatitis CUnited States
-
Cairo UniversityUnknownChronic Hepatitis cEgypt
-
Amr HafezAin Shams UniversityCompleted
-
Karolinska InstitutetThe Swedish Research Council; Hoffmann-La RocheCompletedChronic Hepatitis C | Human Immunodeficiency VirusSweden
-
Bristol-Myers SquibbWithdrawnHepatitis C Virus (HCV)India, Korea, Republic of, Poland, Taiwan, Spain, Canada, Russian Federation, Colombia, Singapore, Netherlands, Ireland, United Kingdom, Czech Republic, Hungary, Romania, Hong Kong, Turkey, United States, China, Egypt
-
Kaohsiung Medical University Chung-Ho Memorial...Completed